Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK1278863A in healthy subjects; the trial related to anemia has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• GSK1278863A (GSK1278863A)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED